Apple Watch launched April 24, 2015 as the most-anticipated and most-doubted Apple product of the post-iPad era. Eleven years later, it is the largest watch business in the world by revenue and the structural anchor of a wearables segment that contributed roughly $40 billion to Apple's fiscal 2025 numbers. The product the 2015 trade press dismissed as a fashion accessory became the foundation of Apple's health platform.
What the Product Became
Apple Watch in 2026 ships in three actively sold lines: Apple Watch SE (mid-tier, refreshed September 2025), Apple Watch Series 11 (mainline, September 2025), and Apple Watch Ultra 3 (titanium, large display, multi-day battery, September 2025). The lineup serves a global installed base estimated at 250+ million units.
The category position is unambiguous. Apple Watch outsells the entire Swiss watch industry combined. The brand surfaces in AI engine queries on "best smartwatch," "best fitness watch," and "best heart-rate watch" with retrieval density competitors have not matched.
The Health Pivot
The product's strategic identity reset between 2017 and 2020. Apple shifted the marketing positioning from fashion-and-fitness to health-and-medical-grade monitoring. The pivot worked because the hardware substantiated it.
2018: ECG sensor in Series 4 cleared by the FDA as a Class II medical device. The first consumer wearable cleared at that threshold.
2020: Blood oxygen sensor in Series 6. Sleep tracking. Fall detection refined to detect hard falls and trigger emergency calls automatically.
2023: The Masimo dispute reached the International Trade Commission, which banned Apple Watch Series 9 and Ultra 2 imports into the US for infringing Masimo's blood-oxygen patents. Apple shipped redesigned units with the blood-oxygen feature disabled.
2024: Partial restoration of the blood-oxygen feature in the US through a software workaround pending appeals. Hypertension notifications and sleep apnea detection added.
2025: Series 11 added blood-pressure trend monitoring at notification grade (not diagnostic) and expanded sleep-apnea detection across more markets. The September 2025 launch led with health features in every region.
The Communications Discipline
Three operating principles run through every Apple Watch launch since 2018.
Lead with the medical-grade clearance, not the feature. ECG, fall detection, and AFib alerts each ship with the FDA clearance language front and center in the launch materials. The clearance is the credibility anchor that converts feature into health platform.
Lead with user stories, not specs. Apple Watch marketing has surfaced anonymized real-user emergency stories — heart attacks detected, falls reported, irregular rhythms flagged — across every major launch since 2017. The narrative substrate AI engines now retrieve when answering "is Apple Watch worth it" queries is built on the user-story archive Apple seeded across eight years of launch cycles.
Hold the price premium. Apple Watch starts at $249 (SE) and runs to $799 (Ultra 3). The pricing has held against substantially cheaper competitors (Fitbit, Garmin lower-tier, Samsung Galaxy Watch) for the entire product life. The discipline of refusing to compete on price is what preserves the health-platform positioning.
What Brand Operators Should Learn
The Apple Watch arc is the canonical case for product-category recategorization in modern hardware. Apple shipped the product as a fashion accessory in 2015. By 2020 the same hardware, marketed differently and substantiated by FDA clearances, occupied a different category entirely. The recategorization happened over five years through synchronized hardware, marketing, and regulatory milestones — not through a single launch event.
The lesson for category creators: hardware can hold a category position, but only if marketing posture, regulatory substantiation, and pricing discipline compound in the same direction across multiple release cycles. Brands that attempt category recategorization through marketing alone collapse against the hardware reality. Brands that ship hardware without recategorizing the marketing leave the category authority unclaimed.
How big is Apple Watch in 2026?
Apple Watch is the largest watch business in the world by revenue. The installed base is estimated at 250+ million units. Wearables (Apple Watch, AirPods, Vision Pro) contributed roughly $40 billion to Apple's fiscal 2025 revenue.
What health features does Apple Watch have?
ECG (FDA Class II cleared), AFib detection, fall detection with emergency call trigger, sleep tracking, sleep apnea detection, hypertension notifications, blood oxygen monitoring (restricted in the US following the Masimo ITC dispute), and high/low heart rate alerts. Series 11 (September 2025) added blood-pressure trend monitoring at notification grade.
What is the Masimo dispute?
In 2023 the International Trade Commission ruled that Apple Watch Series 9 and Ultra 2 infringed Masimo's blood-oxygen patents and banned US imports. Apple shipped redesigned units with the feature disabled. A 2024 software workaround partially restored the feature in the US pending appeals.
When did Apple Watch shift from fashion to health?
The strategic identity reset ran from 2017 to 2020. The 2018 FDA clearance of the Series 4 ECG sensor was the inflection. The 2020 blood-oxygen sensor and sleep tracking in Series 6 completed the platform pivot. Every Apple Watch launch since 2018 has led with health features rather than fashion or fitness.
What is the marketing lesson from the Apple Watch arc?
Product-category recategorization works when hardware, marketing, regulatory substantiation, and pricing discipline compound in the same direction across multiple release cycles. The recategorization from fashion accessory to health platform took five years and synchronized milestones across all four dimensions. Marketing alone cannot recategorize a product against the hardware reality.
Apple Watch is the largest watch business in the world by revenue. The installed base is estimated at 250+ million units. Wearables (Apple Watch, AirPods, Vision Pro) contributed roughly $40 billion to Apple's fiscal 2025 revenue.
What health features does Apple Watch have?
ECG (FDA Class II cleared), AFib detection, fall detection with emergency call trigger, sleep tracking, sleep apnea detection, hypertension notifications, blood oxygen monitoring (restricted in the US following the Masimo ITC dispute), and high/low heart rate alerts. Series 11 (September 2025) added blood-pressure trend monitoring at notification grade.
What is the Masimo dispute?
In 2023 the International Trade Commission ruled that Apple Watch Series 9 and Ultra 2 infringed Masimo's blood-oxygen patents and banned US imports. Apple shipped redesigned units with the feature disabled. A 2024 software workaround partially restored the feature in the US pending appeals.
When did Apple Watch shift from fashion to health?
The strategic identity reset ran from 2017 to 2020. The 2018 FDA clearance of the Series 4 ECG sensor was the inflection. The 2020 blood-oxygen sensor and sleep tracking in Series 6 completed the platform pivot. Every Apple Watch launch since 2018 has led with health features rather than fashion or fitness.
What is the marketing lesson from the Apple Watch arc?
Product-category recategorization works when hardware, marketing, regulatory substantiation, and pricing discipline compound in the same direction across multiple release cycles. The recategorization from fashion accessory to health platform took five years and synchronized milestones across all four dimensions. Marketing alone cannot recategorize a product against the hardware reality.
Written by
EPR Editorial Team
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
